Dene Peters (@drugsjournal) 's Twitter Profile
Dene Peters

@drugsjournal

The Editor of Drugs, the definitive journal of drugs and therapeutics, providing independent and crucial information by leading clinicians and researchers.

ID: 121073996

linkhttp://www.springer.com/adis/journal/40265 calendar_today08-03-2010 10:59:07

944 Tweet

284 Followers

409 Following

David van Duin (@davidvanduin) 's Twitter Profile Photo

#IDTwitter Do you treat patients? please fill out survey by Annette Westgeest & @VanceFowler5 on management of S. aureus bacteremia. It should take < 15 minutes, is IRB approved, voluntary, and anonymous. Please RT  Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 Gabe 🦊 Erin McCreary redcap.duke.edu/redcap/surveys…

Martin Hoenigl🇺🇦🇦🇹 (@martinhoenigl) 's Twitter Profile Photo

Please visit our CLINICAL MYCOLOGY YouTube Channel posting videos of some of the latest and 🔥🔥 scientific webinars educational presentations in the field. Never miss an update by Subscribing here👇 youtube.com/channel/UCKdGf…

Please visit our

CLINICAL MYCOLOGY <a href="/YouTube/">YouTube</a>  Channel 

posting videos of some of the latest and 🔥🔥 scientific webinars educational presentations in the field. 

Never miss an update by
Subscribing here👇
youtube.com/channel/UCKdGf…
Kathy Fraser (@amjclinderma) 's Twitter Profile Photo

Let Springer Nature support you in the fight against #monkeypox. Explore Springer Nature’s curated collection of articles and book chapter. Additionally, don’t miss out to check the trials related to monkeypox: bit.ly/3T3fUbo

Let Springer Nature support you in the fight against #monkeypox. Explore Springer Nature’s curated collection of articles and book chapter. Additionally, don’t miss out to check the trials related to monkeypox: bit.ly/3T3fUbo
Drugs Real World Outcomes (@drugsrwoutcomes) 's Twitter Profile Photo

This #realworld study investigated safety and clinical outcomes of macitentan in a post-marketing study involving Korean patients with pulmonary arterial #hypertension enrolled from 50 medical centers #OpenAccess Full-text available here: link.springer.com/article/10.100…

Drugs Real World Outcomes (@drugsrwoutcomes) 's Twitter Profile Photo

NEW "Trends in the Use of Sedative-Hypnotics, #OPIOIDS, and Neuromuscular Blockers in Hospitalized Patients During the #COVID19 Pandemic" 👉Rapid changes in the use of these #DRUGS were evident during 2020 in Colombia. Full-text: link.springer.com/article/10.100… #OpenAccess

Dene Peters (@drugsjournal) 's Twitter Profile Photo

Adis Insight reports on first approvals just published in Dene Peters Lenacapavir (Sunlenca®) for HIV-1 infection and Valoctocogene roxaparvovec (ROCTAVIAN™) for haemophilia link.springer.com/journal/40265/…

Dene Peters (@drugsjournal) 's Twitter Profile Photo

Just published in Dene Peters Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors by Editorial Board members Francesco Locatelli and Lucia Del Vecchio and colleagues link.springer.com/article/10.100…

Dene Peters (@drugsjournal) 's Twitter Profile Photo

Just published in the latest issue of Dene Peters First Approvals on Darinaparsin (Darvias®) for peripheral T-cell lymphoma; Teclistamab (TECVAYLI®) for multiple myeloma and Valemetostat tosilate (EZHARMIA®) for non-Hodgkin lymphomas link.springer.com/journal/40265/…

Dene Peters (@drugsjournal) 's Twitter Profile Photo

The innovative Silicon Valley-based medical journal, Cureus, is now part of the health division of Springer Nature - helping to solve some challenges of open access publishing. group.springernature.com/gp/group/media…

Dene Peters (@drugsjournal) 's Twitter Profile Photo

Great review on gabapentinoids (gabapentin or pregabalin) for pain just published in Dene Peters with authors suggesting prescribers should be cautious, particularly with using these agents for a prolonged period #pain link.springer.com/article/10.100…

Dene Peters (@drugsjournal) 's Twitter Profile Photo

Just published in the latest issue of Dene Peters First Approvals on ozoralizumab (Nanozora®) for rheumatoid arthritis and tremelimumab-actl (IMJUDO®) for a range of malignant tumours link.springer.com/journal/40265/…

Dene Peters (@drugsjournal) 's Twitter Profile Photo

First original research for the year in Dene Peters, "An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers" from Roger Brüggemann and colleagues link.springer.com/article/10.100…

Dene Peters (@drugsjournal) 's Twitter Profile Photo

In patients with osteoarthritis or back pain, there were no differential risks of incident #Covid_19 diagnosis or COVID-19 hospitalisation for #ibuprofen users compared with other ns-NSAIDs, COX-2i or paracetamol. link.springer.com/article/10.100…

Dene Peters (@drugsjournal) 's Twitter Profile Photo

Latest issue of Dene Peters now available online link.springer.com/journal/40265/… C. difficile infection, refractory #SLE, autoimmune #epilepsy syndromes, intraperitoneal chemotherapy, Nirsevimab (Beyfortus®) in #RSV and Rezvilutamide (艾瑞恩®) in #prostatecancer

Dene Peters (@drugsjournal) 's Twitter Profile Photo

Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure - leading article by Professor Yun-Fan Liaw, Liver Research Unit, Chang Gung University College of Medicine, Taiwan just published in Dene Peters #HepatitisB link.springer.com/article/10.100…